Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
株式のランク #17923
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
株価
$18.20
最終同期: 2025-05-09
時価総額
$220.35M
変化(1日)
-5.34%
変化(1年)
0.00%
JP
取引 I'rom Group Co., Ltd. (2372)

カテゴリー

I'rom Group Co., Ltd.(2372)の発行済株式数
December 2024 時点の発行済株式数 12.11M
I'rom Group Co., Ltd. の最新の財務報告および株価によると、現在の発行済株式数は 12.11M です。March 2023 の終わりには、同社は 12.09M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
I'rom Group Co., Ltd.(2372)の発行済株式数の履歴(2005 ~ 2026)
各年末時点の発行済株式数
発行済株式数 変化
2026 (TTM) 12.11M -0.02%
2024 12.11M 0.11%
2023 12.09M 0.19%
2022 12.07M 0.45%
2021 12.02M 2.87%
2020 11.68M 0.23%
2019 11.66M 1.23%
2018 11.51M 5.84%
2017 10.88M 2.51%
2016 10.61M 3.46%
2015 10.26M 7.29%
2014 9.56M 2.23%
2013 9.35M 0.00%
2012 9.35M 0.00%
2011 9.35M 0.00%
2010 9.35M 0.00%
2009 9.35M 0.00%
2008 9.35M 0.13%
2007 9.34M 0.69%
2006 9.28M 11.44%
2005 8.32M 0.00%
類似企業や競合他社の発行済株式数